FORT LAUDERDALE, Fla. and WALL, N.J., June 21, 2022 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (Nasdaq: BKYI), an innovative provider of Identity and Access Management (IAM) and Identity-Bound Biometric (IBB) solutions, will showcase its solutions in Booth #536 at MSP EXPO June 21-24, 2022 at the Broward County Convention Center, Fort Lauderdale, Florida. Produced by TMC, MSP EXPO is the premier conference and networking summit for Managed Service Providers (MSPs), with expanded reach via its collocation with ITEXPO. BIO-key looks to both support and expand its growing base of Managed Service Providers (MSPs) and Managed Security Service Providers (MSSPs), highlighting the value and capabilities of its differentiated cybersecurity solutions and sharing strategies with channel partners on how to grow their businesses with BIO-key solutions.
BIO-key welcomes the opportunity to extend its Channel Alliance Partner (CAP) Program within the global MSP community and to develop new revenue opportunities for BIO-key and its partners. Attendees are invited to stop by booth #536 to learn how BIO-key and their award-winning PortalGuard IAM platform can:
- Build a strong recurring revenue stream for their business;
- Differentiate their cybersecurity portfolio with Identity-Bound Biometrics;
- Offer an IAM solution that beats the competition in both features and price;
- Build profitable customer relationships; and
- Help them become a trusted cybersecurity advisor.
For more than 20 years, the conference has brought together MSP business owners and technology specialists to discuss how to drive more recurring revenue, increase the valuation of their company, grow their network, deliver better customer service, and evaluate today’s most sought-after technologies.
“We’re seeing more MSPs and a new cohort of MSSPs interested in offering cybersecurity solutions which are a growing customer priority in today’s environment,” said Fred Corsentino, Chief Revenue Officer, BIO-key. “Increases in cyberattacks, cyber insurers requiring multi-factor authentication, the desire to eliminate passwords and providing friction-less access are just some of the reasons customers have a strong interest in our solutions. We look forward to connecting with the global MSP community at this event to discuss how we can help them solve these challenges for their customers and accelerate the grow of their cybersecurity business.”
BIO-key PortalGuard offers an unmatched variety of multi-factor authentication (MFA) choices, single sign-on (SSO), self-service password reset (SSPR (News - Alert)), and Identity-Bound Biometrics. PortalGuard is well-suited for everyday use cases including remote workforces, third-party access, Customer IAM (CIAM), and passwordless workflows. For over 20 years, PortalGuard has been trusted by customers across education, healthcare, manufacturing, finance, government, and other sectors to reduce password-related help desk calls by up to 95%, eliminate passwords, secure remote access, prevent phishing attacks, meet cyber insurance requirements, and improve productivity for the IT team.
For information about BIO-key and its CAP Program please visit the company website. For information about MSP Expo, please visit the conference website.
About BIO-key International, Inc. (www.BIO-key.com)
BIO-key has over two decades of expertise in providing authentication technology for thousands of organizations and millions of users and is revolutionizing authentication with biometric-centric, multi-factor identity and access management (IAM) solutions, including its PortalGuard IAM solution, that provides convenient and secure access to devices, information, applications, and high-value transactions. BIO-key's patented software and hardware solutions, with industry leading biometric capabilities, enable large-scale on-premises and cloud-based Identity-as-a-Service (IDaaS) solutions, as well as customized enterprise solutions.
About TMC (News - Alert) (www.tmcnet.com)
Through education, industry news, live events such as ITEXPO (News - Alert) and social influence, global buyers rely on TMC's content-driven marketplaces to make purchase decisions and navigate markets. As a result, leading technology vendors turn to TMC for unparalleled branding, thought leadership and lead generation opportunities. Our in-person and online events deliver unmatched visibility and sales prospects for all participants. Through our custom lead generation programs, we provide clients with an ongoing stream of leads that turn into sales opportunities and build databases. Additionally, we bolster brand reputations with the millions of impressions from display advertising on our news sites and newsletters. Making TMC a 360-degree marketing solution, we offer comprehensive event and road show management services and custom content creation with expertly ghost-crafted blogs, press releases, articles and marketing collateral to help with SEO, branding, and overall marketing efforts. For more information about TMC and to learn how we can help you reach your marketing goals, please visit www.tmcnet.com and follow us on Facebook, LinkedIn and Twitter, @tmcnet.
BIO-key Safe Harbor Statement
All statements contained in this press release other than statements of historical facts are "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995 (the "Act"). The words "estimate," "project," "intends," "expects," "anticipates," "believes," and similar expressions are intended to identify forward-looking statements. Such forward-looking statements are made based on management's beliefs, as well as assumptions made by, and information currently available to, management pursuant to the "safe harbor" provisions of the Act. These statements are not guarantees of future performance or events and are subject to risks and uncertainties that may cause actual results to differ materially from those included within or implied by such forward-looking statements. These risks and uncertainties include, without limitation, our history of losses and limited revenue; our ability to raise additional capital; our ability to protect our intellectual property; changes in business conditions; changes in our sales strategy and product development plans; changes in the marketplace; continued services of our executive management team; security breaches; competition in the biometric technology industry; market acceptance of biometric products generally and our products under development; the duration and severity of the current coronavirus COVID-19 pandemic and its effect on our business operations, sales cycles, personnel, and the geographic markets in which we operate; delays in the development of products and statements of assumption underlying any of the foregoing as well as other factors set forth under the caption see "Risk Factors'' in our Annual Report on Form 10-K for the year ended December 31, 2021 and other filings with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made. Except as required by law, the Company undertakes no obligation to disclose any revision to these forward-looking statements whether as a result of new information, future events, or otherwise. Additionally, there may be other factors of which the Company is not currently aware that may affect matters discussed in forward-looking statements and may also cause actual results to differ materially from those discussed. In particular, the consequences of the coronavirus outbreak to economic conditions and the industry in general and the financial position and operating results of our Company, in particular, have been material, are changing rapidly, and cannot be predicted.
Engage with BIO-key
Facebook (News - Alert) – Corporate: https://www.facebook.com/BIOkeyInternational/
LinkedIn – Corporate: https://www.linkedin.com/company/bio-key-international
Twitter (News - Alert) – Corporate: @BIOkeyIntl
Twitter – Investors: @BIO_keyIR
Matter on behalf of BIO-key
William Jones, David Collins
Media and Analyst Contact:
Edited by Erik Linask